Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 February 2021 | Story Dr Nitha Ramnath | Photo Supplied
Likeleli Monyamane.

In our first episode of the Voices of the Free State podcast series, Likeleli Monyamane takes us through her journey as a student at the UFS. Founder of Inspire Innovation Business Consultants, Likeleli is a chartered accountant based in Lesotho, with a deep passion for skills development and mentorship. ‘Build people, build the nation’ is the motto that Likeleli subscribes to. Losing her parents at a young age, Likeleli was raised by her grandmother and forged ahead despite the challenges she faced. Commitment to her vision and inspiration from her mum, which left an imprint on her, was what kept Likeleli grounded.

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series. 

Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021.  Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important.

The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them. 

 
Our podcast guest

A chartered accountant by profession, Likeleli Monyamane is founder of Inspire Innovation Business Consultants and Head of Strategy, Projects and Innovation at Alliance Insurance. As a recipient of the Mandela Washington Fellowship, Likeleli attended the Cambridge College in Massachusetts, USA.  She was also selected as one of the Top 35-under-35 chartered accountants by the South African Institute of Chartered Accountants. 

Stay tuned for episode two to be released on 1 March 2021, featuring Bertus Jacobs, Chief Technology Officer of IoT.nxt. 

For further information regarding the podcast series, or to propose other alumni guests, please email us at alumnipodcast@ufs.ac.za 

Listen to the Podcast here:

News Archive

UFS takes a leading role in nuclear medicine and technology
2011-12-06

 
Photo: Dr Glen Taylor

The University of the Free State (UFS) continues to play an active role in the field of Nuclear Medicine and the use of nuclear technology in the biosciences. Dr Glen Taylor, Director of Research Commercialisation and Business Development at the UFS, was recently elected chairperson of the board for the Nuclear Technologies in Medicine and the Biosciences Initiative (NTeMBI).

The UFS is currently one of three centres of excellence in the country identified by the Nuclear Energy Corporation South African (Necsa) to roll out the capacity development programme and increase technology coming from nuclear medicine and technology.
NTeMBI is a national technology platform that is managed by Necsa and supported by the Department of Science and Technology (DST). It functions as a high-level Research, Development and Innovation (RD&I) initiative that will implement new strategic initiatives relating to research and development on nuclear technologies in medicine and the biosciences on a local, regional and international level. 
 
One of the roles Dr Taylor will perform as Chairperson of the board of NTeMBI, is to enhance the exposure of nuclear technology in medicine and the biosciences. Dr Taylor says the aim is to increase the skills base in South Africa. “I realise it is one of the scare skills in the country.” 
 
The UFS already received a significant amount of funding from the grant of R4 million per annum made available from the Department of Science and Technology (DST) to implement NTeMBI projects.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept